CapWealth Advisors LLC Reduces Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

CapWealth Advisors LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,405 shares of the company’s stock after selling 160 shares during the period. CapWealth Advisors LLC’s holdings in HCA Healthcare were worth $1,803,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Centerpoint Advisors LLC acquired a new position in HCA Healthcare in the fourth quarter worth $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $27,000. Bruce G. Allen Investments LLC bought a new position in HCA Healthcare during the 4th quarter worth $28,000. LifeSteps Financial Inc. bought a new stake in HCA Healthcare in the first quarter valued at $33,000. Finally, Rise Advisors LLC bought a new position in shares of HCA Healthcare during the first quarter worth about $36,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.2 %

Shares of HCA traded up $0.58 during mid-day trading on Tuesday, reaching $316.79. The company’s stock had a trading volume of 1,202,958 shares, compared to its average volume of 1,104,113. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $344.20. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The company has a market cap of $82.97 billion, a price-to-earnings ratio of 15.79, a price-to-earnings-growth ratio of 1.48 and a beta of 1.68. The business has a fifty day moving average of $326.96 and a 200 day moving average of $319.44.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. During the same quarter in the prior year, the company earned $4.93 EPS. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. As a group, analysts forecast that HCA Healthcare, Inc. will post 20.97 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were paid a $0.66 dividend. The ex-dividend date of this dividend was Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Analyst Upgrades and Downgrades

Several research analysts have commented on HCA shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Barclays boosted their price target on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research report on Monday, April 29th. Robert W. Baird started coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a research note on Tuesday. Finally, Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Four equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $326.53.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the transaction, the executive vice president now owns 29,624 shares in the company, valued at $9,387,253.12. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 in the last three months. Corporate insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.